[Pharmacological treatment of polycystic ovary syndrome - health and quality of life in the short and long term]
Record ID 32018013640
Swedish
Original Title:
Läkemedelsbehandling av polycystiskt ovarialsyndrom - hälsa och livskvalitet på kort och lång sikt
Authors' objectives:
The aim of the report is to describe how different pharmacological treatments affect the risk of complications in the long and short term in patients with PCOS. The following questions have been formulated:
Can different pharmacological treatments for PCOS reduce the risk of cardio-metabolic complications, risk factors and/or change quality of life in the long and short term?
Can pharmacological treatments for PCOS reduce the risk of cancer and pre-cancerous conditions?
How effective is glucagon-like peptide-1 receptor agonists (GLP-1-RAs) for women with PCOS?
What is the cost-effectiveness of treatment with GLP-1-RAs for PCOS?
Details
Project Status:
Ongoing
URL for project:
https://www.sbu.se/en/ongoing-projects/pharmacological-treatment-of-polycystic-ovary-syndrome---health-and-quality-of-life-in-the-short-and-long-term/
Anticipated Publish Date:
2025
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Sweden
MeSH Terms
- Drug Therapy
- Polycystic Ovary Syndrome
- Ovarian Cysts
- Glucagon-Like Peptide-1 Receptor Agonists
- Ovarian Diseases
- Hypoglycemic Agents
Contact
Organisation Name:
Swedish Agency for Health Technology Assessment and Assessment of Social Services
Contact Address:
SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services, P.O. Box 6183, SE-102 33 Stockholm, Sweden. Tel: +46 8 4123200, Fax: +46 8 4113260
Contact Name:
registrator@sbu.se
Contact Email:
registrator@sbu.se
Copyright:
SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.